Order Article Reprints

Faron A, Opheys NS, Nowak S, Sprinkart AM, Isaak A, Theis M, Mesropyan N, Endler C, Sirokay J, Pieper CC, et al. Deep Learning-Based Body Composition Analysis Predicts Outcome in Melanoma Patients Treated with Immune Checkpoint Inhibitors. Diagnostics. 2021; 11(12):2314. https://doi.org/10.3390/diagnostics11122314

Faron, Anton, Nikola S. Opheys, Sebastian Nowak, Alois M. Sprinkart, Alexander Isaak, Maike Theis, Narine Mesropyan, Christoph Endler, Judith Sirokay, Claus C. Pieper, and et al. 2021. "Deep Learning-Based Body Composition Analysis Predicts Outcome in Melanoma Patients Treated with Immune Checkpoint Inhibitors" Diagnostics 11, no. 12: 2314. https://doi.org/10.3390/diagnostics11122314

Faron, A., Opheys, N. S., Nowak, S., Sprinkart, A. M., Isaak, A., Theis, M., Mesropyan, N., Endler, C., Sirokay, J., Pieper, C. C., Kuetting, D., Attenberger, U., Landsberg, J., & Luetkens, J. A. (2021). Deep Learning-Based Body Composition Analysis Predicts Outcome in Melanoma Patients Treated with Immune Checkpoint Inhibitors. Diagnostics, 11(12), 2314. https://doi.org/10.3390/diagnostics11122314